Transduction of the gene coding for a human G-protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity

International Immunopharmacology

Volumn 5, Issue 6, 2005, Pages 971-980

  Hu, Jinyue ^a,b   Li, Guancheng ^a   Tong, Yongqing ^a   Li, Yuehui ^a   Zhou, Guohua ^a   He, Xiaojuan ^a   Xie, Pingli ^a   Wang, Ji Ming ^b   Sun, Qubing ^a  

^a Central South University   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chemoattractant receptors; Colorectal cancer; Gene therapy; Gene transfer

Indexed keywords

FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; G PROTEIN COUPLED RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; COLON CANCER; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; GENETIC TRANSDUCTION; IMMUNE RESPONSE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR REJECTION; WILD TYPE;

EID: 17044369479     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2005.01.011     Document Type: Article

References (40)

1. H. Hewitt, E. Blake, and A. Walder A critique of the evidence for active host defense against cancer, based on person studies of 27 murine tumors of spontaneous origin Cancer 33 1976 241 259
2. A. van Pel, and T. Boon Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis Proc Natl Acad Sci U S A 79 1982 4718 4722
3. E. Giboa The makings of a tumor rejection antigen Immunity 11 1999 263 270
4. Y. Kawakami, S. Eliyahu, C.H. Delgado, P.F. Robbins, L. Rivoltini, and S.L. Topalian Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor Proc Natl Acad Sci U S A 91 1994 3515 3519
5. P. van der Bruggen, C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, and B. Van den Eynde A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma Science 254 1991 1643 1647
6. T. Wolfel, M. Hauer, J. Schneider, M. Serrano, C. Wolfel, and E. Klehmann-Hieb A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma Science 269 1995 1281 1284
7. C.G. Ioannides, B. Fisk, D. Fan, W.E. Biddison, J.T. Wharton, and C.A. O'Brian Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene Cell Immunol 151 1993 225 234
8. + T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene Proc Natl Acad Sci U S A 91 1994 9461 9465
9. R.F. Wang, X. Wang, A.C. Atwood, S.L. Topalian, and S.A. Rosenberg Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen Science 284 1999 1351 1354
10. + T cell: receptor-dependent cytolysis in the absence of interleukin-2 production Science 251 1991 1228 1230
11. I. Melero, N. Bach, and L. Chen Costimulation, tolerance and ignorance of cytolytic T lymphocytes in immune responses to tumor antigens Life Sci 60 1997 2035 2041
12. D.N. Contreras, P.H. Krammer, R.K. Potkul, P. Bu, J.L. Rossi, and A.M. Kaufmann Cervical cancer cells induce apoptosis of cytotoxic T lymphocytes J Immunother 23 2000 67 74
13. R. Kiessling, K. Wasserman, S. Horiguchi, K. Kono, J. Sjogerg, and P. Pisa Tumor-induced immune dysfunction Cancer Immunol Immunother 48 1999 353 362
14. P.T. Golumbek, A.J. Lazenby, H.I. Levitsky, L.M. Jaffee, H. Karasuyama, and M. Baker Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4 Science 254 1999 713 716
15. L. Chen, S. Ashe, W.A. Brady, I. Hellstrom, K.E. Hellstrom, and J.A. Ledbetter Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 Cell 71 1992 1093 1102
16. K. Tanaka, H. Hayashi, C. Hamada, G. Khoury, and G. Jay Expression of major histocompatibility complex class I antigens as a strategy for the potentiation of immune recognition of tumor cells Proc Natl Acad Sci U S A 63 1986 8723 8727
17. R. Srinivasan, and J.D. Wolchok Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines J Transl Med 2 2004 12
18. Y.Q. Wei, Q.R. Wang, X. Zhao, L. Yang, L. Tian, and Y. Lu Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine Nat Med 6 2000 1160 1166
19. K. Wei, J.G. Wilson, C.H. Hurgensen, M.A. Iannone, G. Wolberg, and B.E. Huber Xenogeneic ICAM-1 gene transfer suppresses tumorigenicity and generates protective antitumor immunity Gene Ther 3 1996 531 541
20. I. Campbell, T. Myoana, S. Carlsen, C. Zheng, and J. Xiang Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth Cancer Gene Ther 7 2000 37 44
21. R. Hock, B. Reynold, C. Tucker-McClung, and W. Kwok Human class II major histocompatibility complex gene transfer into murine neuroblastoma leads to loss of tumorigenicity, immunity against subsequent tumor challenge, and elimination of microscopic preestablished tumors J Immunother 17 1995 12 18
22. R.D. Ye, S.L. Cavanagh, O. Quehenberger, E.R. Prossnitz, and C.G. Cochrane Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor Biochem Biophys Res Commun 184 1992 582 589
23. E.L. Becker, F.A. Forouhar, M.L. Grunnet, F. Boulay, M. Tardif, and B.J. Bormann Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells Cell Tissue Res 292 1998 129 135
24. X. Deng, H. Ueda, S.B. Su, W. Gong, N.M. Dunlop, and J.L. Gao A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R Blood 94 1999 1165 1173
25. J.Y. Hu, Y. Le, W. Gong, N.M. Dunlop, J.L. Gao, and P.M. Murphy Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1 J Leukoc Biol 70 2001 155 161
26. J.L. Gao, H. Chen, J.D. Filie, C.A. Kozak, and P.M. Murphy Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse Genomics 51 1998 270 276
27. N. Sato, M.C. Michaelides, and M.K. Wallack Characterization of tumorigenicity, mortality, metastasis, and splenomegaly of two cultured murine colon lines Cancer Res 41 1981 2267 2272
28. C. Naftzger, Y. Takechi, H. Kohda, I. Hara, S. Vijayasaradhi, and A.N. Houghton Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity Proc Natl Acad Sci U S A 93 1996 14809 14814
29. L.W. Weber, W.B. Bowne, J.D. Wolchok, R. Srinivasan, J. Qin, and Y. Moroi Tumor immunity and autoimmunity induced by immunization with homologous DNA J Clin Invest 102 1998 1258 1264
30. W.B. Bowne, R. Srinivasan, J.D. Wolchok, W.G. Hawkins, N.E. Blachere, and R. Dyall Coupling and uncoupling of tumor immunity and autoimmunity J Exp Med 190 1999 1717 1722
31. W.G. Hawkins, J.S. Gold, N.E. Blachere, W.B. Bowne, A. Hoos, and J.J. Lewis Xenogeneic DNA immunization in melanoma models for minimal residual disease J Surg Res 102 2002 137 143
32. W.G. Hawkins, J.S. Gold, R. Dyall, J.D. Wolchok, A. Hoos, and W.B. Bowne Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity Surgery 128 2000 273 280
33. Y. Lu, Y.Q. Wei, L. Tian, X. Zhao, L. Yang, and B. Hu Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor J Immunol 170 2003 3162 3170
34. Q.M. He, Y.Q. Wei, L. Tian, X. Zhao, J.M. Su, and L. Yang Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice J Biol Chem 278 2003 21831 21836
35. P.J. Bergman, J. McKnight, A. Novosad, S. Charney, J. Farrelly, and D. Craft Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial Clin Cancer Res 9 2003 1284 1290
36. S.A. Kalams, and B.D. Walker The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses J Exp Med 188 1998 2199 2204
37. K.L. Knutson, K. Schiffman, and M.L. Disis Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients J Clin Invest 107 2001 477 484
38. R. Moses, R. Pierson, H. Winn, and H. Auchincloss Xenogeneic proliferation and lymphokine production are dependent on CD4 helper T cells and self antigen-presenting cells in the mouse J Exp Med 172 1990 567 575
39. A.C. Wallgren, A. Karlsson-Parra, and O. Korsgren The main infiltrating cell in xenograft rejection is a CD4 macrophage and not a T lymphocyte Transplantation 60 1995 594 601
40. Y. Le, P.M. Murphy, and J.M. Wang Formyl-peptide receptors revisited Trends Immunol 23 2002 541 548